Publication: Repeated exposure to opisthorchis viverrini and treatment with the antihelminthic praziquantel lacks carcinogenic potential
dc.contributor.author | Witaya Thamavit | en_US |
dc.contributor.author | Malcolm A. Moore | en_US |
dc.contributor.author | Somsak Ruchirawat | en_US |
dc.contributor.author | Nobuyuki Ito | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Nagoya City University Medical School | en_US |
dc.date.accessioned | 2018-08-10T08:44:11Z | |
dc.date.available | 2018-08-10T08:44:11Z | |
dc.date.issued | 1992-02-01 | en_US |
dc.description.abstract | The effects of repeated Praziquantel administration, subsequent to infection and reinfection w Opisthorchis viverrini (OV), on lesion development in the Syrian hamster liver were investigated. Five applications of the antihelminthic drag were made (300 mg/kg body wt, i.g.), each time ∼5 weeks after dosing with 60-80 OV metacercarine at weeks 0, 8, 16, 24 and 32. The animals were then maintained until week 40 when they were killed; histopathological investigation revealed no significant development of either hepatocellular of cholangiocellular preneoplastic/neoplastic lesions. The results indicate that repeated exposure to Praziquantel at levels sufficient for successful removal of parasite infestation does not itself carry carcinogenic risk. © 1992 Oxford University Press. | en_US |
dc.identifier.citation | Carcinogenesis. Vol.13, No.2 (1992), 309-311 | en_US |
dc.identifier.doi | 10.1093/carcin/13.2.309 | en_US |
dc.identifier.issn | 01433334 | en_US |
dc.identifier.other | 2-s2.0-0026567040 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/22258 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0026567040&origin=inward | en_US |
dc.subject | Biochemistry, Genetics and Molecular Biology | en_US |
dc.title | Repeated exposure to opisthorchis viverrini and treatment with the antihelminthic praziquantel lacks carcinogenic potential | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0026567040&origin=inward | en_US |